Controversies in Thyroidology: Clinical Application of Molecular Testing in the Treatment of Advanced and Metastatic Thyroid Carcinoma

Naifa L. Busaidy Related Seminars and Products

Naifa Busaidy, MD  is a Tenured Associate Professor in the Department of Endocrine Neoplasia & Hormonal Disorders at the University of Texas – MD Anderson Cancer Center.  Her clinical expertise and research interests are primarily focus driven to treat and improve outcomes in patients with aggressive thyroid carcinomas. Dr Busaidy went to Baylor College of Medicine for medical school and her internal medicine residency. She completed her Endocrine fellowship at the combined program of Baylor College of Medicine and the University of Texas - MD Anderson Cancer Center. Her additional research fellowship year at MD Anderson advanced her clinical and research knowledge in Endocrine Tumors. She joined the faculty at UT MD Anderson Cancer Center in 2004 and climbed the ranks to Tenured Associate Professor.  She serves on several institutional committees. There, she also directs the thyroid nodule clinic where they see patients with the spectrum of the disease from initial visit to diagnosis on the same day with results.  As an oncologic endocrinologist, she serves as Principal Investigator and Co-Investigator of both National Cancer Institute sponsored and industry sponsored trials and publishes on several clinical trials identifying the molecular mechanisms of disease progression and identify targets for improving response to therapy. She serves on the National Comprehensive Cancer Network (NCCN) Thyroid Cancer Guidelines Committee.  She has served as the Endocrine expert on the National Cancer Institute’s PI3K/mTOR taskforce.  As well as advisory boards and as a consultant for oncology groups and industry to shape the treatment spectrum of thyroid cancer today.  Dr. Busaidy’s service to the American Thyroid Association includes the program committee, research grant committee and the awards committee. She is a member of the International Thyroid Oncology Group Board, AACE, Endocrine Society and several societies where she enjoys serving on multiple committees including mentorship and research committees.  She is a fellow of the American Association of Clinical Endocrinologists. She has published extensively on Endocrine tumors, specifically thyroid cancer and Endocrine effects of cancer therapy.

Mimi Hu Related Seminars and Products

Mimi Hu, MD graduated from Rice University with a degree in mechanical engineering. She obtained her medical degree from the University of Texas - Houston Health Sciences Center. She completed her residency and endocrine fellowship at Baylor College of Medicine, where she also served as chief medical resident. After completion of her research fellowship at MD Anderson, she joined the faculty in 2007 in the department of Endocrine Neoplasia and Hormonal Disorders. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma (differentiated and medullary), hereditary endocrine neoplasia disorders and metabolic bone and mineral disorders. She is the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders. She is the director of the Oncologic Endocrine Fellowship program at MD Anderson, the first-of-its-kind training program to provide specialized education in the care and management of patients with endocrine neoplasias/cancers or endocrine complications from cancer or its treatments.

Mark E. Zafereo Related Seminars and Products

Mark E. Zafereo, Jr., MD is an Associate Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Endocrine Center at MD Anderson Cancer Center. Dr. Zafereo holds national committee appointments for the American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, and American Board of Otolaryngology-Head and Neck Surgery, and he is a Past President of the Houston Society of Otolaryngology-Head and Neck Surgery. He has published extensively on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.

Whitney S. Goldner, MD Related Seminars and Products

Dr. Whitney Goldner

University of Nebraska Medical Center

Whitney Goldner, MD is an Endocrinologist at the University of Nebraska Medical Center, Omaha, NE. She is an Associate Professor of Medicine in the Division of Diabetes, Endocrinology, and Metabolism, Dept of Internal Medicine. She is the PI of ICaRe2, which is a bioinformatics registry and biospecimen bank at UNMC for thyroid nodules and thyroid cancer. She specializes in thyroid disease, thyroid nodules, and thyroid cancer as well as neuroendocrine tumors and other Endocrine disorders. She is the Endocrinology Fellowship Program director and runs the thyroid ultrasound and biopsy clinics.

Kepal Patel Related Seminars and Products

Kepal N. Patel, MD is the Chief of the Division of Endocrine Surgery and an Associate Professor of Surgery, Otolaryngology and Biochemistry at NYU Langone Medical Center. He is the Director of the Thyroid Interdisciplinary Program and has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid disease along with other head and neck tumors. He also leads the translational research program for the Division of Endocrine Surgery. Dr. Patel has been studying the molecular pathogenesis of thyroid carcinoma by focusing on the changes in intracellular pathways that lead to the progression of thyroid cancer. His research interests also include studying the relationship of autoimmune thyroiditis to thyroid cancer at the genomic level.
He earned his M.D. from UMDNJ-Robert Wood Johnson Medical School and completed his Oncologic Head and Neck Surgery training at Memorial Sloan-Kettering Cancer Center. Dr. Patel’s work has been recognized by numerous awards from prestigious societies such as the American Society of Clinical Oncology, American Head and Neck Society, American Association of Endocrine Surgeons, and the American Thyroid Association. He currently serves in multiple leadership roles both locally and nationally and is a reviewer and on the editorial board of several journals.